Elicio Therapeutics Statistics
Total Valuation
ELTX has a market cap or net worth of $92.09 million. The enterprise value is $86.47 million.
Market Cap | 92.09M |
Enterprise Value | 86.47M |
Important Dates
The next estimated earnings date is Wednesday, May 15, 2024, before market open.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ELTX has 10.22 million shares outstanding. The number of shares has increased by 1,500.08% in one year.
Shares Outstanding | 10.22M |
Shares Change (YoY) | +1,500.08% |
Shares Change (QoQ) | -39.64% |
Owned by Insiders (%) | 45.06% |
Owned by Institutions (%) | 5.31% |
Float | 5.39M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 8.19 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.61.
Current Ratio | 1.67 |
Quick Ratio | n/a |
Debt / Equity | 0.61 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -32.23 |
Financial Efficiency
Return on equity (ROE) is -160.20% and return on invested capital (ROIC) is -195.43%.
Return on Equity (ROE) | -160.20% |
Return on Assets (ROA) | -102.40% |
Return on Capital (ROIC) | -195.43% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.10M |
Employee Count | 32 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.84% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | +48.84% |
50-Day Moving Average | 5.82 |
200-Day Moving Average | 7.14 |
Relative Strength Index (RSI) | 73.28 |
Average Volume (30 Days) | 65,743 |
Short Selling Information
The latest short interest is 39,524, so 0.39% of the outstanding shares have been sold short.
Short Interest | 39,524 |
Short Previous Month | 28,405 |
Short % of Shares Out | 0.39% |
Short % of Float | 0.73% |
Short Ratio (days to cover) | 0.78 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.75M |
Pretax Income | -35.20M |
Net Income | -35.20M |
EBITDA | -32.97M |
EBIT | -34.14M |
Earnings Per Share (EPS) | -$6.96 |
Balance Sheet
The company has $13.62 million in cash and $6.92 million in debt, giving a net cash position of $6.70 million or $0.66 per share.
Cash & Cash Equivalents | 13.62M |
Total Debt | 6.92M |
Net Cash | 6.70M |
Net Cash Per Share | $0.66 |
Equity / Book Value | 11.37M |
Book Value Per Share | 1.11 |
Working Capital | 6.58M |
Cash Flow
In the last 12 months, operating cash flow was -$32.69 million and capital expenditures -$32,000, giving a free cash flow of -$32.73 million.
Operating Cash Flow | -32.69M |
Capital Expenditures | -32,000 |
Free Cash Flow | -32.73M |
FCF Per Share | -$6.47 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ELTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,500.08% |
Shareholder Yield | -1,500.08% |
Earnings Yield | -37.78% |
FCF Yield | -35.13% |
Analyst Forecast
The average price target for ELTX is $11.00, which is 22.09% higher than the current price. The consensus rating is "Buy".
Price Target | $11.00 |
Price Target Difference | 22.09% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 2, 2023. It was a reverse split with a ratio of 1:10.
Last Split Date | Jun 2, 2023 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |